SCHEMBL3362001

SCHEMBL3362001

[CH2]c1cc(=O)[nH]c(=O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11726927 0.67 CA1 (0.44)
SCHEMBL1673294 0.67
SCHEMBL8188652 0.67
SCHEMBL317622 0.67
SCHEMBL13918178 0.67
SCHEMBL60308 0.67
SCHEMBL325682 0.67
SCHEMBL1774205 0.67
SCHEMBL1896344 0.67
SCHEMBL29207894 0.65 CA1 (0.95)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177521-A1 PROCESS FOR THE PREPARATION OF DEGARELIX Fresenius Kabi Ipsum S.R.L. (IT) 2022-06-09 US claimed
EP-3935072-A1 PROCESS FOR THE PREPARATION OF DEGARELIX Fresenius Kabi iPSUM S.r.l. (IT) 2022-01-12 EP claimed
US-6359061-B1 COMBINATORIAL LIBRARIES ARE USEFUL FOR SCREENING IN BIOLOGCAL ASSAYS IN ORDER TO IDENTIFY PHARMACEUTICALLY USEFUL COMPOUNDS ISIS PHARMACEUTICALS, INC. 2002-03-19 US claimed
US-6316623-B1 USEFUL FOR SCREENING IN BIOLOGICAL ASSAYS IN ORDER TO IDENTIFY PHARMACEUTICALLY USEFUL COMPOUNDS ISIS PHARMACEUTICALS, INC. 2001-11-13 US claimed
US-5395838-A Aromatic aminomethyl substitutes compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-03-07 US claimed
EP-0373891-B1 Anti-tumour agents ICI PLC (GB) 1994-11-02 EP claimed
EP-0373891-A2 Anti-tumour agents IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-20 EP claimed
US-4386073-A ANTIDOTES TO EFFECTS OF CERTAIN DRUGS PATENTBUREAU DANUBIA (HU) 1983-05-31 US claimed
US-3944550-A Vitamin E orotate and a method of producing the same KANEBO LTD. (JA) 1976-03-16 US claimed
CN-116327957-A Combination of agonist anti-PD-1 antibodies with GnRH agonists or GnRH antagonists for the treatment of cancer 德彪药业国际股份公司 2023-06-27 CN disclosed
CN-111727060-B Agonist anti-PD-1 antibodies in combination with GnRH agonists or GnRH antagonists for the treatment of cancer 德彪药业国际股份公司 2023-04-11 CN disclosed
US-20220177521-A1 PROCESS FOR THE PREPARATION OF DEGARELIX Fresenius Kabi Ipsum S.R.L. (IT) 2022-06-09 US disclosed
EP-3935072-A1 PROCESS FOR THE PREPARATION OF DEGARELIX Fresenius Kabi iPSUM S.r.l. (IT) 2022-01-12 EP disclosed
CN-111727060-A Agonist anti-PD-1 antibodies in combination with GnRH agonists or GnRH antagonists for the treatment of cancer 德彪药业国际股份公司 2020-09-29 CN disclosed
EP-0373891-A2 Anti-tumour agents IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-20 EP disclosed
US-4725581-A NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS ADIR ET COMPAGNIE (FR) 1988-02-16 US disclosed
EP-0217688-A1 Peptide derivatives with a lactonic or cycloamidic structure, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1987-04-08 EP disclosed
US-4386073-A ANTIDOTES TO EFFECTS OF CERTAIN DRUGS PATENTBUREAU DANUBIA (HU) 1983-05-31 US disclosed
US-4386073-A ANTIDOTES TO EFFECTS OF CERTAIN DRUGS PATENTBUREAU DANUBIA (HU) 1983-05-31 US disclosed
US-3944550-A Vitamin E orotate and a method of producing the same KANEBO LTD. (JA) 1976-03-16 US disclosed